Celcuity Inc. (CELC) Dividend History

Celcuity Inc. (CELC) is a biotechnology company focused on developing personalized cancer therapies through its innovative molecular and cellular analysis platform. The company utilizes its proprietary diagnostic technology to identify specific patient subgroups, enabling targeted treatments and improving clinical outcomes. Celcuity aims to translate complex biological data into actionable insights for better cancer treatment strategies.

16305 36th Avenue N, Minneapolis, MN, 55446
Phone: 763-392-0767
Website: https://www.celcuity.com

Dividend History

Celcuity Inc. currently does not pay dividends

Company News

Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention

Cancer research companies are attracting investor interest as the oncology market is projected to grow significantly, with several firms showing promising clinical trial results and strategic developments in cancer treatments.

Benzinga

Featured Companies: CTOR EXEL
Celcuity To Participate in Jefferies Global Healthcare Conference

MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024.

GlobeNewswire Inc.
Why Celcuity (CELC) Might Surprise This Earnings Season

Celcuity (CELC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research
Why Celcuity Stock Is Crashing Today

The clinical-stage biotech announced the pricing of a secondary stock offering.

The Motley Fool

Featured Companies: PFE

Page data last updated 07/23/2025 17:05:19 UTC